Weight-Loss Drugs Like Wegovy Don't Lower Cancer Risks: Study

A new study looked at popular weight-loss drugs like Wegovy and Zepbound to see if they help lower the risk of cancers linked to obesity.

The study found that these drugs don't seem to reduce the risk of these cancers.

The researchers looked at data from many previous studies involving over 94,000 people.

They found that while these drugs help with weight loss and improving metabolic health, they don't lower the risk of cancers like thyroid, pancreatic, breast, or kidney cancer.

The study also couldn't say for sure how these drugs affect the risk of other cancers like colorectal, esophageal, liver, and gastric cancers because there wasn't enough data.

The researchers said more long-term studies are needed to fully understand the effects of these drugs on cancer risk.